Clinical Validation of <scp>ADAM9</scp> as a Prognostic Biomarker in Oral Cancer
This study identifies ADAM9 as a key driver of oral cancer in a Taiwanese cohort and highlights its diagnostic and therapeutic potential.
Authors
- Show‐Mei Chuang (ORCID: https://orcid.org/0000-0003-2986-0736)
- Yun‐Jung Tsai
- Wu‐Chun Tu (ORCID: https://orcid.org/0000-0002-9882-9778)
- Jeng‐Wei Lu (ORCID: https://orcid.org/0000-0003-2128-2046)
- Ming-Horng Tsai (ORCID: https://orcid.org/0000-0003-0343-2370)
- Shu‐Hui Lin (ORCID: https://orcid.org/0000-0002-5157-9986)
- Pei‐Chen Shih
Institutions
- University of Copenhagen (DK)
- National Taiwan Ocean University (TW)
- National Chung Hsing University (TW)
- Rigshospitalet (DK)
- Changhua Christian Hospital (TW)
- Central Taiwan University of Science and Technology (TW)
Publication Details
- Journal
- Oral Diseases
- Published
- 2025-06-16
- DOI
- https://doi.org/10.1111/odi.15383
- Citations
- 1
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.85
Funders
- National Chung-Hsing University
- Changhua Christian Hospital